Cepheid (NASDAQ:CPHD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 0.02%.
Cepheid Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased 0% to $0.02 in the quarter versus EPS of $0.02 in the year-earlier quarter.
Revenue: Rose 18.49% to $96 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Cepheid reported adjusted EPS income of $0.02 per share. By that measure, the company beat the mean analyst estimate of $-0.04. It beat the average revenue estimate of $92.57 million.
Quoting Management: Chairman and Chief Executive John L. Bishop on Thursday said, “With backorders of Xpert test cartridges now behind us, and with new leadership and a new organizational structure in manufacturing operations, we are investing aggressively and driving across-the-board improvements to ensure that Cepheid is well prepared to effectively manage the growing demand for our rapidly expanding Xpert test menu.”
Key Stats (on next page)…
Revenue increased 4.42% from $91.94 million in the previous quarter. EPS increased to $0.02 in the quarter versus EPS of $0.00 in the previous quarter.
Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a loss of $0 and has not changed. For the current year, the average estimate has moved down from a profit of $0.01 to a loss of $0 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)